MINI FUTURE LONG - VIRBAC Share Price

Certificat

DE000MB1S9W1

Real-time Bid/Ask 05:30:02 27/05/2024 pm IST
13.92 EUR / 14.05 EUR +0.83% Intraday chart for MINI FUTURE LONG - VIRBAC
Current month+6.04%
1 month-3.41%
Date Price Change
27/24/27 14.16 +2.09%
24/24/24 13.87 -1.84%
23/24/23 14.13 +1.07%
22/24/22 13.98 +1.23%
21/24/21 13.81 +2.52%

Delayed Quote Börse Stuttgart

Last update May 27, 2024 at 03:24 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying VIRBAC
Issuer Morgan Stanley
WKN MB1S9W
ISINDE000MB1S9W1
Date issued 27/12/2022
Strike 219.4
Maturity Unlimited
Parity 10 : 1
Emission price 3.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 15.67
Lowest since issue 2.91
Spread 0.13
Spread %0.93%

Company Profile

Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
More about the company

Ratings for Virbac

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Virbac

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
360 EUR
Average target price
372.4 EUR
Spread / Average Target
+3.46%
Consensus